Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2018, Article ID 1717843, 8 pages
https://doi.org/10.1155/2018/1717843
Research Article

The Early Outcomes of Nurse Case Management in Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator: A Prospective Randomized Controlled Trial

1Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand
2Faculty of Nursing, Mahidol University, Bangkok 10700, Thailand

Correspondence should be addressed to Sombat Muengtaweepongsa; moc.liamtoh@mtabmos

Received 30 January 2018; Revised 23 April 2018; Accepted 14 May 2018; Published 7 June 2018

Academic Editor: Vincenzo Di Lazzaro

Copyright © 2018 Urai Kummarg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. Murray, “Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data,” The Lancet, vol. 367, no. 9524, pp. 1747–1757, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. Stroke epidemiological data of nine Asian countries, “Asian Acute Stroke Advisory Panel (AASAP),” Journal of the Medical Association of Thailand, vol. 83, pp. 1–7, 2000. View at Google Scholar
  3. N. Poungvarin, “Burden of stroke in Thailand,” International Journal of Stroke, vol. 2, no. 2, pp. 127-128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Hanchaiphiboolkul, N. Poungvarin, S. Nidhinandana et al., “Prevalence of stroke and stroke risk factors in thailand: Thai epidemiologic stroke (TES) study,” Journal of the Medical Association of Thailand, vol. 94, no. 4, pp. 427–436, 2011. View at Google Scholar · View at Scopus
  5. S. Palangrit and S. Muengtaweepongsa, “Risk factors of stroke in Pathumthani Province, Thailand,” Journal of the Medical Association of Thailand, vol. 98, no. 7, pp. 649–655, 2015. View at Google Scholar · View at Scopus
  6. Tissue plasminogen activator for acute ischemic stroke, “The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group,” The New England Journal of Medicine, vol. 333, pp. 1581–1587, 1995. View at Google Scholar
  7. W. Hacke, M. Kaste, E. Bluhmki et al., “Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke,” The New England Journal of Medicine, vol. 359, no. 13, pp. 1317–1329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Muengtaweepongsa, W. Hunghok, and T. Harnirattisai, “Poor recognition of prompted treatment seeking even with good knowledge of stroke warning signs contribute to delayed arrival of acute ischemic stroke patients in Thailand,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 5, pp. 948–952, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. E. C. Jauch, B. Cucchiara, O. Adeoye et al., “Part 11: Adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation, vol. 122, no. 3, pp. S818–S828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Muengtaweepongsa, P. Dharmasaroja, and U. Kummark, “Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: Initial experience of a community-based hospital in a developing country,” Journal of Stroke and Cerebrovascular Diseases, vol. 21, no. 1, pp. 42–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. White and M. E. Hall, “Mapping the literature of case management nursing,” Journal of the Medical Library Association, vol. 94, pp. 99–106, 2006. View at Google Scholar
  12. J. K. Allen, R. S. Blumenthal, S. Margolis, D. R. Young, E. R. Miller III, and K. Kelly, “Nurse case management of hypercholesterolemia in patients with coronary heart disease: Results of a randomized clinical trial,” American Heart Journal, vol. 144, no. 4, pp. 678–686, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ireland, G. MacKenzie, L. Gould, D. Dassinger, A. Koper, and K. LeBlanc, “Nurse case management to improve risk reduction outcomes in a stroke prevention clinic,” Canadian Journal of Neuroscience Nursing, vol. 32, no. 4, pp. 7–13, 2010. View at Google Scholar · View at Scopus
  14. C. M. Baker, I. Miller, M. Sitterding, and C. J. Hajewski, “Acute stroke patients comparing outcomes with and without case management,” Nursing Case Management, vol. 3, no. 5, pp. 196–203, 1998. View at Google Scholar · View at Scopus
  15. M. W. Lipsey, “The experimental paradigm,” Evaluation Practice, vol. 11, no. 1, pp. 99-100, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. E. C. Jauch, J. L. Saver, H. P. Adams et al., “Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 44, no. 3, pp. 870–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee, “Guidelines for management of ischaemic stroke and transient ischaemic attack 2008,” Cerebrovascular Disease, vol. 25, pp. 457–507, 2008. View at Publisher · View at Google Scholar
  18. W. Hacke, G. Donnan, C. Fieschi et al., “Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials,” The Lancet, vol. 363, no. 9411, pp. 768–774, 2004. View at Publisher · View at Google Scholar
  19. G. C. Fonarow, X. Zhao, E. E. Smith et al., “Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative,” Journal of the American Medical Association, vol. 311, no. 16, pp. 1632–1640, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Muengtaweepongsa, P. Prapa-Anantachai, P. A. Dharmasaroja, P. Rukkul, and P. Yodvisitsak, “External validation of the SEDAN score: The real world practice of a single center,” Annals of Indian Academy of Neurology, vol. 18, no. 2, pp. 181–186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. G. D. Graham, “Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data,” Stroke, vol. 34, no. 12, pp. 2847–2850, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. L. Saver, “Hemorrhage after thrombolytic therapy for stroke: The clinically relevant number needed to harm,” Stroke, vol. 38, no. 8, pp. 2279–2283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. A. Potter, A. G. Perry, P. Stockert, and A. Hall, Theoretical Foundations of Nursing Practice in Fundamentals of Nursing, Chapter 3, Elsevier Health Sciences, 2013.
  24. S. M. Nettina, A.-B. Msn, and S. M. Nettina, Nursing Practicing and the Nursing Process in Lippincott Manual of Nursing Practice, Chapter 1, Lippincott Williams and Wilkins, 2013.
  25. E. H. Wagner, “The role of patient care teams in chronic disease management,” British Medical Journal, vol. 320, no. 7234, pp. 569–572, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. C. J. Huston, “The role of the case manager in a disease management program,” Lippincott's Case Management, vol. 6, no. 5, pp. 222–227, 2001. View at Google Scholar